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UVA1 Induces Cyclobutane Pyrimidine Dimers
but Not 6-4 Photoproducts in Human Skin In Vivo
Angela Tewari1, Robert P. Sarkany1 and Antony R. Young1
UVB readily induces cyclobutane pyrimidine dimers, mainly thymine dimers (TTs), and pyrimidine (6-4)
pyrimidone photoproducts (6-4PPs) in DNA. These lesions result in ‘‘UVB signature mutations’’ found in skin
cancers. We have investigated the induction of TTs and 6-4PPs in human skin in vivo by broadband UVA1, and
have compared this with comparable erythemal doses of monochromatic UVB (300 nm). In vitro and ex vivo
studies have shown the production of TTs, without 6-4PPs, by UVA1. We show that UVA1 induces TTs, without
6-4PPs, in the epidermis of healthy volunteers in vivo, whereas UVB induced both photoproducts. UVB induced
more TTs than UVA1 for the same level of erythema. The level of UVA1-induced TTs increased with epidermal
depth in contrast to a decrease that was seen with UVB. UVA1- and UVB-induced TTs were repaired in epidermal
cells at a similar rate. The mechanism by which UVA1 induces TTs is unknown, but a lack of intra-individual
correlation between our subjects’ UVB and UVA1 minimal erythema doses implies that UVA1 and UVB erythema
occur by different mechanisms. Our data suggest that UVA1 may be more carcinogenic than has previously
been thought.
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INTRODUCTION
Solar UVR is the main cause of skin cancer (Armstrong and
Kricker, 2001), and UVB (290–320nm) has generally been
thought of as the major carcinogen. However, UVA
(320–400nm) is 20 times more abundant than UVB in
terrestrial UVR, and around 75% of solar UVA is UVA1
(340–400 nm). On average, an indoor worker is exposed to
1,500 J cm2 UVA exposure per year (Diffey, 1996). UVA is
the predominant waveband emitted by sunbeds despite
recent classification as a carcinogen to humans (El Ghissassi
et al., 2009), and UVA1 is increasingly used for phototherapy
for skin diseases (Dawe, 2003; York and Jacobe, 2010).
Although the action spectrum for induction of squamous
cell carcinoma in mice has a major UVB peak, there is also
a smaller peak in the UVA1 region (de Gruijl et al., 1993).
It has been reported that UVA causes melanoma precursors
in Monodelphis domestica (Ley, 1997), and melanoma in
Xiphophorus fish (Setlow, 1974; Setlow et al., 1993), but this
has been recently refuted (Mitchell et al., 2010). A role for
UVA in human skin cancer has been proposed (Drobetsky
et al., 1995; Agar et al., 2004), which is supported by some
epidemiological data for melanoma (Garland et al., 2003).
DNA absorbs UVB, and UVA to a smaller degree (Setlow,
1974; Sutherland and Griffin, 1981; Young et al., 1996).
Absorption of UVB causes the formation of cyclobutane
pyrimidine dimers (CPDs) and pyrimidine (6-4) pyrimidone
photoproducts (6-4PPs). These lesions are repaired by the
excision repair pathway, but when unrepaired can form the
classic ‘‘UVB signature’’ mutations: C-T or CC-TT (Ziegler
et al., 1996), which are found in skin cancers.
UVA is also mutagenic, but its genetic effects have
been mainly attributed to UVA excitation of non-DNA
chromophores, resulting in reactive oxygen species-induced
base oxidation to form products such as 8-oxo-7,8-dihydro-
guanine, as well as DNA single-strand breaks (Cadet et al.,
2009). UVB also induces 8-oxo-7,8-dihydroguanine (Ravanat
et al., 2001).
Unexpectedly, studies in cultured cells and whole explant
skin have shown that CPDs are induced by UVA1 in larger
amounts than oxidatively generated lesions (Douki et al.,
2003; Mouret et al., 2006). In addition, the classic CPD-
induced ‘‘UVB signature’’ mutation C:G-T:A has been
found to be the most common mutation induced by UVA
(41% of mutations; Rochette et al., 2003; Kappes et al.,
2006). This has raised doubts about the relative mutagenicity
and carcinogenicity of UVA and UVB in human skin as the
‘‘UVB signature’’ mutations found in skin cancers, including
melanoma, may also be caused by UVA.
Interestingly, unlike UVB, UVA1 produces cyclobutane
thymine dimers (TTs) in vitro and ex vivo but few CC, CT, and
no 6-4PP or their Dewar isomers (Douki et al., 2003; Mouret
et al., 2006). An indirect photosensitized triplet energy
transfer mechanism with UVA1 was originally suggested to
explain this (Cadet et al., 2009), but this is no longer thought
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to be the case (see discussion). UVA1 induction of CPDs has
been studied in vitro and ex vivo (Mouret et al., 2006).
However, the important issue of the role of UVA1 in CPD
formation in vivo has not been studied.
We therefore aimed to measure the formation of TTs and
6-4PPs in humans in vivo by comparable erythemal doses
of UVA1 and UVB (300nm). Erythema was used as the
comparator because it is a key response to UV damage, and
human action spectroscopy has specifically implicated TT
formation as a trigger for erythema (Young et al., 1998). In
addition to induction, we assessed the repair of photoproducts
with UVA1 and UVB in vivo, because it has been reported
that TT repair is slower ex vivo after UVA1 than UVB, which is
relevant to the formation of mutations (Mouret et al., 2006).
RESULTS
Erythema
Comparable levels of erythema were achieved for the
same multiple of the notional minimal erythema dose
(MED; see Material and Methods for definition) for both
UVB and UVA1 (Figure 1a). This is a fixed physical dose
based on the mean MED of three individuals (see Materials
and Methods). The slope for UVB was steeper than that for
UVA1 (P¼ 0.0006); there was no correlation between a given
individual’s UVB and UVA1 MED (Figure 1b).
Epidermal localization of TT and quantification of depth of
staining
Figure 2a and b shows anti-TT antibody staining after UVA1
and UVB, immediately after exposure to three notional
0.0 0.5 1.0 1.5 2.0
0
100
200
a
b
UVA1
UVB
Notional MED
Δ 
Er
yt
he
m
a 
in
de
x
±S
D
0.00 0.01 0.02 0.03 0.04
0
10
20
30
40
50
60
70
33
2
300 nm MED (J cm–2)
UV
A1
 M
ED
 (J
 cm
–
2 )
Figure 1. UVA1- and UVB-induced erythema. (a) Quantitative erythema
dose responses for UVB (300 nm) and UVA1. These data were obtained from
the individual MED assessments series and are plotted against notional MED
fractions. The slopes for both spectra are highly significant (Po0.001).
(b) Lack of relationship between a given individual’s UVB and UVA1 MED,
n¼ 12: note numbers on the figure correspond to the number of volunteers
with the same UVB and UVA MEDs. MED, minimal erythema dose.
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Figure 2. Immunostaining of UV-irradiated epidermis. Typical microscope
images of (a) UVA1 and (b) UVB assessed immediately after exposure to three
notional MEDs. Note more intense red (cyclobutane thymine dimer, TT)
staining at basal epidermis with UVA1 and more intense red staining in upper
epidermis with UVB. (c) Quantification of TT staining on a nucleus-per-
nucleus basis with epidermal depth for 12 volunteers. The lines were
generated by linear regression and both slopes were significant (Pp0.01).
Bars¼ 50 mm (a) and 50 mm (b). MED, minimal erythema dose.
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MEDs. All isotype controls were negative (data not shown).
UVA1 caused more intense staining in the lower epidermis,
whereas UVB led to more intense upper epidermal staining.
We quantified the relationship between staining intensity and
epidermal depth by linear regression analysis to a depth of
10 nuclei (Figure 2c, n¼12). With UVB there was a
significant (P¼0.01) reduction in TT staining with increased
epidermal depth. In contrast, for UVA1, there was a
significant (Po0.001) increase in staining with increased
depth.
Dose dependence of photoproduct formation
For a given multiple of notional MED, UVA1 produced fewer
TTs than UVB (Figure 3): the slope for UVB is 3.4-fold steeper
than that with UVA1 (P¼0.00096). Immediately after
exposure to UVB, 4.4 times more TTs were found than with
a comparable dose of UVA1 (Figure 4a). 6-4PPs are induced
by UVB in a dose-dependent manner but no 6-4PPs at all are
induced with UVA1 at any dose in vivo (Figure 3).
Repair kinetics of CPD and 6-4PP
The slopes for the loss of UVB- and UVA1-induced TTs with
time are not significantly different (P¼0.71). By 48 hours,
the majority of the UVA1-induced TTs had disappeared
(Figure 4a). However, UVB-induced TTs are still present
because 3MED UVB induces more TTs than 3MED UVA1.
Repair of UVB-induced 6-4PPs was very fast (Figure 4b), as
we previously reported in vivo (Young et al., 1996; Bykov
et al., 1999) for UVB using solar-simulated radiation.
The comparable repair rate for TTs induced by both
spectra suggests that the same host repair machinery is used.
Our data are different from published ex vivo studies (Mouret
et al., 2006) that suggest that UVB-induced TTs were repaired
faster than those induced by UVA1.
DISCUSSION
We have shown that UVA1 readily induces TTs but not
6-4PPs in human skin in vivo. To our knowledge this is
previously unreported in humans in vivo, as is the compar-
ison of the effects of UVA1 to erythemally equivalent doses of
UVB. Our maximum doses for UVB (300 nm) and UVA1
were 90mJ cm2 and 148 J cm2 compared with 20mJ cm2
and 200 J cm2, respectively, used in the previous study using
ex vivo skin (Mouret et al., 2006). As the UVB in that study
was primarily at 312 nm, those exposures would have been
sub-erythemal as MEDs for skin type I/II at 312 nm are
200–300mJ cm2 (Palmer et al., 2006); thus, previous ex vivo
studies have not used UVA1 and UVB doses with comparable
erythemal potential. Erythema is widely accepted as the
biologically relevant measure of acute UVR exposure (e.g., a
sunscreen’s sun protection factor is measured by its protective
effect against erythema). Our data show comparable levels
of erythema for UVA1 and UVB for a given notional
MED fraction (Figure 1a), although the dose response for
UVB is significantly steeper. The absence of any correlation
(Figure 1b) between an individual’s UVB and UVA1 MED
suggests that UVA1 erythema may involve a different
mechanism. Epidermal DNA is thought to be an important
chromophore for UVB erythema induction (Young et al.,
1998). When it produces approximately the same intensity of
erythema, UVA1 induces 3- to 4-fold fewer TTs than UVB.
This implies that other chromophores may be important for
UVA1 erythema. The second UVA1 peak identified in one
action spectrum of human erythema also points to the
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Figure 3. Dose responses for cyclobutane thymine dimer and 6-4PP with
UVB (300 nm) and UVA1. The lines were generated by linear regression.
Note: in one case the volunteer was inadvertently given a different dose
series. 6-4PP, pyrimidine (6-4) pyrimidone photoproduct; CPD, cyclobutane
pyrimidine dimer; MED, minimal erythema dose.
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Figure 4. Repair of epidermal photolesions. (a) Repair kinetics of
cyclobutane thymine dimer and (b) pyrimidine (6-4) pyrimidone
photoproduct after three notional MEDs UVB (300 nm) and UVA1.
The lines were generated by linear regression and the slopes are not
significantly different (P¼ 0.71).
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chromophores possibly being different for UVA1 (Anders
et al., 1995). UVB-induced erythema is oxygen independent,
whereas UVA erythema is oxygen dependent (Auletta et al.,
1986), implying a role for reactive oxygen species in UVA
erythema.
The majority of CPDs induced by UVA1 are TTs (Mouret
et al., 2006), and we show the presence of UVA1-induced
TTs using an antibody technique, although it is possible that
some cytosine-containing CPDs were also induced because
the antibody is not 100% TT specific (see Materials and
Methods). TTs are much less mutagenic than CC and CT
(Pfeifer et al., 2005), but are more persistent in human skin
in vivo because of slower repair than CC (Bykov et al., 1999;
Xu et al., 2000). However, in vitro studies have shown that
UVA1 readily induces C-T transitions, widely associated
with UVB-induced CPDs (Kappes et al., 2006; Runger and
Kappes, 2008), which is probably the result of UVA1-induced
cytosine-containing CPDs (Mouret et al., 2006).
An ex vivo study found that UVA1-induced TTs are
repaired less well than those induced by UVB (Mouret et al.,
2006), as with our study there were about four times more
TTs with UVB compared with UVA1. Our repair kinetics data
show that this is not the case in vivo. UVA1-induced TTs
were repaired at the same rate as those induced by UVB
(Figure 4a). As UVA1 produced fewer CPDs than UVB, repair
was almost complete after 48 hours. These data suggest that
the degree of initial DNA damage, from an acute exposure,
determines the amount of damage that remains a day or
two later. However, in vitro studies suggest that the rate of
CPD repair from a single exposure may decrease with
higher doses, possibly resulting from damage to the DNA
repair machinery (Greinert et al., 2000; Courdavault
et al., 2004). The situation may be different with repeated
daily sub-erythemal exposure, which results in the accumu-
lation of TTs (Young et al., 2007). Limited evidence exists
that repeated sub-erythemal exposure enhances TT repair
in skin types III/IV but not in I/II (Sheehan et al., 2002).
In contrast, mice exposed to chronic low-dose UVB show
decreased CPD repair in response to a challenge dose
(Mitchell et al., 1999).
The photochemical mechanism by which UVA1 selec-
tively induces TTs remains unknown. UVA activation of some
photosensitizers such as fluoroquinolones (Makinen et al.,
1997) and carprofen (Robinson et al., 2010) can induce
CPDs in vitro, suggesting that unidentified endogenous
photosensitizers might have a role in the induction of TTs
by UVA1. However, double-stranded base sequences
(e.g., dA.dT) increase UVA absorption compared with the
same monomeric molecules (Mouret et al., 2010) and UVA
induction of TTs seems to be due to a direct photochemical
mechanism without involvement of a cellular photosensitizer
(Jiang et al., 2009; Mouret et al., 2010). The lack of 6-4PPs
with UVA suggests that the photochemical process is different
from that with UVB and UVC; however, this remains to be
elucidated.
It is intriguing that UVB predominantly induced TTs in the
superficial epidermis, whereas UVA1-induced TTs were more
prominent in the lower epidermis (Figure 2). A similar depth
effect has been found in staining for p53 protein expression at
24 hours (Campbell et al., 1993) with UVB (300±5 nm) and
UVA (350±30 nm). There are very few data on the optical
properties of skin in the UVR region. Such photons may be
absorbed by chromophores (e.g., DNA) or scattered by the
epidermis and dermis in a forward or backward direction,
and scattering may be considered more important than
absorption (Anderson and Parrish, 1981; van Gemert et al.,
1989). Overall, skin chromophores absorb primarily in the
UVB region. Back scattering results in remittance (a type of
‘‘reflection’’), which provides additional opportunity for
chromophore absorption during the return pathway. Dermal
remittance increases between 300 and 400nm (Anderson
and Parrish, 1981). Thus, it is possible that the higher
number of UVA1-induced To4T seen in the basal layer is
due to dermal back scatter (e.g., from collagen), as well as
epidermal forward scatter (Bruls and van der Leun, 1984).
Irrespective of any mutagenic potential for TTs, our data
suggest that UVA1 preferentially targets the stem cell-
containing basal layer. This may be significant for skin
cancer because more UVA fingerprint mutations are found in
the basal layer compared with the suprabasal layer in
squamous cell carcinomas and actinic keratoses (Agar
et al., 2004). Furthermore, studies on engineered human
skin show that, in contrast to UVB, UVA-induced muta-
tions were mainly located in the basal layer (Huang et al.,
2009).
In summary, we have demonstrated that erythemally
equivalent doses of UVA1 and UVB induce TTs in human
buttock skin in vivo, but that 6-4PPs are induced by UVB
only. UVB induced more TTs than UVA1 for a given
erythemal exposure. This, along with the lack of correlation
between UVB and UVA1 MED, adds support to the
hypothesis that the chromophores and the mechanism for
UVB and UVA1 erythema are different, although presumably
TTs contribute to UVA1 erythema. Our data suggest that the
basal layer is particularly vulnerable to UVA1-induced
damage and this is supported by some mutagenesis studies.
This has implications for public health policies, particularly
the need for broader waveband population photoprotection.
MATERIALS AND METHODS
Irradiation
UVR sources and dosimetry. Emission spectra and irradiances of
the UVA1 and UVB sources were determined with a DM150BC
double-monochromator spectroradiometer (Bentham Instruments,
Reading, UK) using an integration sphere and gratings blazed at
250 nm (see Figure 5). The UVA1 source was a Sellamed 3000
Dr Sellmeier (Sellas, Gevelsberg, Germany) irradiation device.
Irradiance was routinely measured with a radiometer (Model
IL1400A, International Light Technologies, Peabody, MA), after
calibration against the spectroradiometric measurements, and was
typically about 74mWcm2 at the skin surface, which was 24.5 cm
from the source. Narrowband UVB (300 nm) was produced by a
monochromator (Oriel, Irvine, CA: 1-kW xenon arc; grating blazed
at 250 nm; slits set for 3 nm full width at half maximum bandwidth).
UVB was delivered with a liquid light guide (Oriel), with an exit
diameter of 5mm, in direct contact with the skin. Irradiance
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(B0.5mWcm2) was measured with an SEL623 thermopile (Inter-
national Light Technologies) attached to an IL1400A radiometer
(details as above; detector and meter calibrated by the United
Kingdom Accreditation Service-accredited Guy’s and St Thomas’
Hospitals Trust UVR laboratory).
Volunteers. The studies were approved by the St Thomas’ Hospital,
London, UK, Ethics Committee (ref: 09/H0802/98), and conducted in
accordance with the Declaration of Helsinki Principles. The details
of the 12 healthy skin type I/II (Fitzpatrick, 1988) volunteers are
shown in Table 1. Participants gave written informed consent before
taking part in the study.
Irradiation protocol. A geometric ( 1.25) series of eight doses
was given over 1 cm2 areas of previously unexposed buttock skin.
A visual assessment of the exposed sites was made 24 hours after
exposure and the ‘‘just perceptible MED’’ was determined, a more
reliable threshold end point than ‘‘erythema with a definite border’’
(Quinn et al., 1994). Quantitative reflective spectroscopy to quantify
erythema (erythema meter, Dia-Stron, Andover, UK) was carried out
three times per test site per volunteer, and the mean of the three
measurements calculated. The difference between the measurement
from the test site and that from an adjacent nonirradiated control site
is the D erythema index value.
MEDs were measured in three individuals: mean values 30.0
(SD±0)mJ cm2 for UVB and 48.8 (SD±0) J cm2 for UVA1. These
were defined as the ‘‘notional MED’’ subsequently given to each
volunteer. Table 1 shows that the mean MED for 12 volunteers
were 25.8±4.6mJ cm2 (UVB) and 45.8±9.4 J cm2 (UVA1): the
notional MEDs are within one SD of these values. Punch biopsies
(4mm) were taken under local anesthesia in two studies: (i) ‘‘dose
response’’: six participants were given 0.5, 1.5, and 3 notional MEDs
of UVB and UVA1 and biopsies taken immediately afterward;
(ii) ‘‘time course’’: six participants were given three notional MEDs
of UVA1 and UVB and seven biopsies then taken at three time
points, per spectrum, from each volunteer within the ranges
immediate, 3, 6, 24, and 48 hours. Times varied because of ethical
considerations: all had biopsies at 0 and 24 hours, except for two
UVB sites on two volunteers. A nonirradiated control biopsy was
taken from all volunteers.
Immunostaining. Biopsies were fixed in 10% formalin overnight
(B16hours), embedded in paraffin, and sectioned at 4mm. Sections
were deparaffinized with xylene and incubated with 0.1% trypsin
(Gibco, Paisley, UK) at 37 1C for 30minutes; slides were washed twice
in phosphate-buffered saline (PBS) and incubated in 0.6% H202 and
0.1% triton X-100 in PBS for 10minutes. After washing in tap water,
DNA was denatured with 70mM NaOH in 70% ethanol for 4minutes.
Table 1. Volunteer demographics and their just perceptible MED
Study Skin type Sex Age (years) MED UVA1 (J cm2) MED UVB (mJ cm2)
Dose response I F 28 48.8 30.0
I F 25 48.8 30.0
II M 20 48.8 30.0
II F 21 53.0 30.0
I F 22 48.8 23.0
I M 34 61.1 19.0
Mean±SD M+F 25±5.3 51.6±4.9 27.0±4.8
Time course I F 28 31.3 19
I F 28 31.3 30
I M 22 48.8 23
II F 24 31.3 30
I M 23 48.8 23
II F 23 48.8 23
Mean±SD M+F 24.7±2.7 40.1±9.6 24.7±4.4
Combined I (8), II (4) M (4), F (8) 24.8±4.0 45.8±9.4 25.8±4.6
Abbreviations: F, female; M, male; MED, minimal erythema dose.
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Figure 5. Emission spectra of UVB (300 nm) and UVA1 sources. Note the
very clean separation of the spectra with 3–4 orders of magnitude difference
between peaks and spectral crossover. The UVA2 (230–340 nm) content
of the UVA1 source was 0.2%, which is equivalent to 0.6% of the overall
erythemally effective energy when the emission spectrum is weighted with
the action spectrum for erythema (CIE, 1998).
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Slides were washed twice with PBS and incubated for 20minutes in
blocking buffer (10% goat serum, 0.1% bovine serum albumin, and
0.1% Tween-20 in PBS), followed by monoclonal antibody incuba-
tion for 90minutes at room temperature. The antibodies were TDM-2
(CosmoBio, Tokyo, Japan) at 1:2,000, which has primary specificity to
TTs but also can recognize other CPDs (Mori et al., 1991), and 64M2
(CosmoBio) at 1:300, which has primary specificity to TT 6-4PPs but
also recognizes other 6-4PPs (Mori et al., 1991). In addition, an
isotype control IgG2a (DAKO, Cambridge, UK) was used. After
washing twice in PBS, slides were incubated with Alexa Fluor goat
anti-mouse 555 (Invitrogen, Paisley, UK) at 1:200 for 30minutes,
counterstained with prolong gold antifade with DAPI (Molecular
Probes, Paisley, UK), coverslipped, and stored away from light.
Isotype controls, to exclude nonspecific antibody staining, were
negative in every experiment. The reproducibility of staining and
image analysis was measured for both the dose–response and time-
course studies. Thus, three notional MEDs of UVB or UVA1 (taken
immediately after exposure) were stained with each staining run within
both experiments. Mean nuclear intensities for TTs were (mean±SD)
117.8±7.8 for UVB and 22.4±6.6 for UVA1 (dose response), and
99.6±3.1 for UVB and 36.7±3.1 for UVA1 (time response). For
6-4PPs, the comparable values for the dose response were 29.8±14.2
for UVB and 0±0 for UVA1, and for the time response were
34.9±14.1 for UVB and 0±0 for UVA1. These data indicate that the
staining and imaging analysis techniques were reproducible within a
given experiment.
CPD and 6-4PP quantification by immunofluorescence image
analysis. Fluorescent imaging was done for Alexa Fluor 555 (red) and
DAPI (nuclear DNA stain; blue): Zeiss Axiophot microscope
(Harpenden, UK) and Nikon DS-U2 camera (Kingston upon Thames,
UK) with  20 magnification (and  1.25 eyepiece objective). Images
were acquired in 2,560 1,920 format and exposed to 20S (gain
 1.40 for Alexa Fluor5 55 with 1.5 seconds exposure, gain  1.40
for DAPI). Contrast setting was the same for all images. Epidermis
analysis was done using NIS elements BR v3 software package
(Melville, NY). DAPI-stained nuclei were gated and mean red intensity
(Alexa Fluor 555) assessed within each of at least 200 nuclei. Mean
background intensity from the nonirradiated control also calculated
for over 200 nuclei and subtracted from the irradiated samples to
control for nonspecific nuclear staining (typically higher for 6-4PPs:
44.9±36.7 than TTs: 12.6±6.4 as previously reported (Young et al.,
1996)). Settings for nuclei capture (circularity and diameter of nuclei)
were maintained constant, sections subjectively assessed, and nuclei
‘‘separated and smoothed’’ as necessary. For each biopsy, the mean
intensity value for nuclei in the epidermis was calculated.
Quantification of the distribution of epidermal TT staining.
The ‘‘3MED’’ UVA1 and UVB biopsies, 0 hour, from 12 volunteers
were assessed for nuclear staining intensity on a line perpendicular
to the surface over the thickest section of the epidermis. DAPI-
stained epidermal nuclei were gated and red staining of each
nucleus on the line was individually gated and measured.
Reproducibility of staining and image analysis. It was not
possible to stain and assess all slides in a single batch. To assess the
reproducibility of the techniques, sections prepared from one
individual exposed to three notional MED UVB and UVA1 were
processed with each staining and image analysis run, as well as a
nonirradiated control and an isotype control in each case.
Data analysis
Linear regression analysis was used to study correlation between
UVR dose and outcome. Statistical tests used Graphpad Prism v4
statistics package (La Jolla, CA).
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